Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2024-05-15 Sale |
2024-05-17 4:28 pm |
Denali Therapeutics Inc. | DNLI | SATO VICKI L Director |
1,674 | $20.39 | $34,133 | 116,369 (Direct) |
View |
| 2024-04-15 Sale |
2024-04-17 5:14 pm |
Denali Therapeutics Inc. | DNLI | SATO VICKI L Director |
1,666 | $18.29 | $30,471 | 118,043 (Direct) |
View |
| 2024-04-01 Sale |
2024-04-02 6:07 pm |
Denali Therapeutics Inc. | DNLI | Krognes Steve E. Director |
92,500 | $20.5 | $1,896,250 | 897,341 (Indirect Direct) |
View |
| 2024-03-15 Sale |
2024-03-19 4:27 pm |
Denali Therapeutics Inc. | DNLI | SATO VICKI L Director |
1,666 | $20.1 | $33,487 | 119,709 (Direct) |
View |
| 2024-02-15 Sale |
2024-02-20 5:38 pm |
Denali Therapeutics Inc. | DNLI | SATO VICKI L Director |
1,666 | $18.37 | $30,604 | 121,375 (Direct) |
View |
| 2024-02-13 Sale |
2024-02-15 9:16 pm |
Denali Therapeutics Inc. | DNLI | Krognes Steve E. Director |
2,750 | $17.29 | $47,548 | 989,841 (Indirect Direct) |
View |
| 2024-02-13 Sale |
2024-02-15 9:15 pm |
Denali Therapeutics Inc. | DNLI | Watts Ryan J. President and CEO |
9,589 | $17.29 | $165,794 | 2,480,671 (Indirect Direct) |
View |
| 2024-02-13 Sale |
2024-02-15 9:14 pm |
Denali Therapeutics Inc. | DNLI | Ho Carole Chief Medical Officer |
4,189 | $17.46 | $73,130 | 351,824 (Indirect Direct) |
View |
| 2024-02-13 Sale |
2024-02-15 9:14 pm |
Denali Therapeutics Inc. | DNLI | Schuth Alexander O. COFO and Secretary |
22,844 | $17.62 | $402,420 | 711,090 (Indirect Direct) |
View |
| 2024-01-16 Sale |
2024-01-18 6:26 pm |
Denali Therapeutics Inc. | DNLI | SATO VICKI L Director |
1,666 | $18.42 | $30,688 | 123,041 (Direct) |
View |
| 2024-01-10 Sale |
2024-01-12 8:18 pm |
Denali Therapeutics Inc. | DNLI | Ho Carole Chief Medical Officer |
4,668 | $19.02 | $88,785 | 356,013 (Indirect Direct) |
View |
| 2024-01-09 Sale |
2024-01-11 5:28 pm |
Denali Therapeutics Inc. | DNLI | Watts Ryan J. President and CEO |
7,818 | $19.78 | $154,640 | 2,490,260 (Indirect Direct) |
View |
| 2024-01-05 Sale |
2024-01-09 7:35 pm |
Denali Therapeutics Inc. | DNLI | Ho Carole Chief Medical Officer |
9,972 | $19.43 | $193,756 | 360,681 (Indirect Direct) |
View |
| 2024-01-05 Sale |
2024-01-09 7:34 pm |
Denali Therapeutics Inc. | DNLI | Krognes Steve E. Director |
3,208 | $19.43 | $62,331 | 992,591 (Indirect Direct) |
View |
| 2024-01-05 Sale |
2024-01-09 7:34 pm |
Denali Therapeutics Inc. | DNLI | Schuth Alexander O. COFO and Secretary |
9,972 | $19.43 | $193,756 | 683,934 (Indirect Direct) |
View |
| 2024-01-05 Sale |
2024-01-09 7:33 pm |
Denali Therapeutics Inc. | DNLI | Watts Ryan J. President and CEO |
17,483 | $19.43 | $339,695 | 2,498,078 (Indirect Direct) |
View |
| 2023-12-15 Sale |
2023-12-18 7:30 pm |
Denali Therapeutics Inc. | DNLI | SATO VICKI L Director |
1,666 | $23.39 | $38,968 | 124,707 (Direct) |
View |
| 2023-11-15 Sale |
2023-11-16 6:14 pm |
Denali Therapeutics Inc. | DNLI | SATO VICKI L Director |
1,666 | $19.13 | $31,871 | 126,373 (Direct) |
View |
| 2023-10-16 Sale |
2023-10-18 4:44 pm |
Denali Therapeutics Inc. | DNLI | SATO VICKI L Director |
1,666 | $20.66 | $34,420 | 128,039 (Direct) |
View |
| 2023-09-15 Sale |
2023-09-19 4:45 pm |
Denali Therapeutics Inc. | DNLI | SATO VICKI L Director |
1,666 | $23.62 | $39,348 | 129,705 (Direct) |
View |
| 2023-08-23 Sale |
2023-08-25 5:36 pm |
Denali Therapeutics Inc. | DNLI | Schuth Alexander O. COFO and Secretary |
2,522 | $23.17 | $58,435 | 640,186 (Indirect Direct) |
View |
| 2023-08-23 Sale |
2023-08-25 5:30 pm |
Denali Therapeutics Inc. | DNLI | Ho Carole Chief Medical Officer |
2,522 | $23.22 | $58,561 | 316,933 (Indirect Direct) |
View |
| 2023-08-21 Sale |
2023-08-23 4:34 pm |
Denali Therapeutics Inc. | DNLI | Ho Carole Chief Medical Officer |
2,478 | $22.6 | $56,003 | 319,455 (Indirect Direct) |
View |
| 2023-08-21 Sale |
2023-08-23 4:33 pm |
Denali Therapeutics Inc. | DNLI | Schuth Alexander O. COFO and Secretary |
2,478 | $22.59 | $55,978 | 642,708 (Indirect Direct) |
View |
| 2023-08-21 Sale |
2023-08-23 4:32 pm |
Denali Therapeutics Inc. | DNLI | Watts Ryan J. President and CEO |
2,309 | $22.59 | $52,160 | 2,426,041 (Indirect Direct) |
View |
| 2023-08-21 Sale |
2023-08-23 4:31 pm |
Denali Therapeutics Inc. | DNLI | Krognes Steve E. Director |
1,419 | $22.6 | $32,069 | 995,799 (Indirect Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2024-05-31 Option Award |
2024-06-04 6:33 pm |
N/A 2034-05-31 |
Denali Therapeutics Inc. | DNLI | Krognes Steve E. Director |
23,868 | $0 | 921,209 (Direct) |
View |
| 2024-05-31 Option Award |
2024-06-04 6:32 pm |
N/A 2034-05-31 |
Denali Therapeutics Inc. | DNLI | Thornberry Nancy Director |
23,868 | $0 | 36,581 (Direct) |
View |
| 2024-05-31 Option Award |
2024-06-04 6:31 pm |
N/A 2034-05-31 |
Denali Therapeutics Inc. | DNLI | Tessier-Lavigne Marc Director |
23,868 | $0 | 2,135,309 (Direct) |
View |
| 2024-05-31 Option Award |
2024-06-04 6:30 pm |
N/A 2034-05-31 |
Denali Therapeutics Inc. | DNLI | SATO VICKI L Director |
23,868 | $0 | 140,237 (Direct) |
View |
| 2024-05-31 Option Award |
2024-06-04 6:30 pm |
N/A 2034-05-31 |
Denali Therapeutics Inc. | DNLI | Cook Jennifer E. Director |
23,868 | $0 | 39,397 (Direct) |
View |
| 2024-05-31 Option Award |
2024-06-04 6:29 pm |
N/A 2034-05-31 |
Denali Therapeutics Inc. | DNLI | Schenkein David P Director |
23,868 | $0 | 96,861 (Direct) |
View |
| 2024-05-31 Option Award |
2024-06-04 6:28 pm |
N/A 2034-05-31 |
Denali Therapeutics Inc. | DNLI | FLATLEY JAY T Director |
23,868 | $0 | 364,397 (Direct) |
View |
| 2024-05-31 Option Award |
2024-06-04 6:27 pm |
N/A 2034-05-31 |
Denali Therapeutics Inc. | DNLI | Harris Erik Director |
23,868 | $0 | 34,953 (Direct) |
View |
| 2024-05-31 Option Award |
2024-06-04 6:20 pm |
N/A 2034-05-31 |
Denali Therapeutics Inc. | DNLI | Klein Peter S Director |
23,868 | $0 | 39,397 (Direct) |
View |
| 2024-03-29 Gift |
2024-03-29 5:59 pm |
N/A N/A |
Denali Therapeutics Inc. | DNLI | Watts Ryan J. President and CEO |
40,000 | $0 | 2,440,671 (Indirect) |
View |
| 2024-02-08 Exercise |
2024-02-12 4:48 pm |
N/A N/A |
Denali Therapeutics Inc. | DNLI | Schuth Alexander O. COFO and Secretary |
50,000 | $0.68 | 879,012 (Direct) |
View |
| 2024-02-08 Exercise |
2024-02-12 4:48 pm |
N/A 2025-08-20 |
Denali Therapeutics Inc. | DNLI | Schuth Alexander O. COFO and Secretary |
50,000 | $0 | 879,012 (Direct) |
View |
| 2024-01-03 Option Award |
2024-01-05 5:57 pm |
N/A 2034-01-02 |
Denali Therapeutics Inc. | DNLI | Schuth Alexander O. COFO and Secretary |
214,880 | $0 | 855,066 (Direct) |
View |
| 2024-01-03 Option Award |
2024-01-05 5:57 pm |
N/A 2034-01-02 |
Denali Therapeutics Inc. | DNLI | Ho Carole Chief Medical Officer |
214,880 | $0 | 531,813 (Direct) |
View |
| 2024-01-03 Option Award |
2024-01-05 5:56 pm |
N/A 2034-01-02 |
Denali Therapeutics Inc. | DNLI | Watts Ryan J. President and CEO |
358,080 | $0 | 2,784,121 (Direct) |
View |